Merrimack Pharmaceuticals Aktie

7,835 -3,81% -0,3105 €
22:31 Uhr L&S RT | Mehr Kurse »
WKN: A2DW3Q
ISIN: US5903282094
US-Symbol: MACK
Typ: Aktie

Performance Merrimack Pharmaceuticals Aktie

  
1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 9,08 $ 8,71 $ 9,32 $ 10,25 $ 14,60 $ 122,90 $
Änderung +0,77% +5,05% -1,82% -10,73% -37,33% -92,55%

Forum zur Merrimack Pharmaceuticals Aktie

  
iTechDachs: Einige erwarten für Juli etwas
21.06.18
Options Traders Expect Huge Moves in Merrimack Pharmaceuticals (MACK) StockInvestors in Merrimack Pharmaceuticals (MACK) need to pay close attention to the stock based on moves in the options market lately.https://finance.yahoo.com/news/options-​traders-expect-...
biotech1x1: News vom 24.03.2016
30.03.16
Merrimack Announces Inclusion of ONIVYDE® (irinotecan liposome injection) as a Category 1 Treatment Option in the 2016 NCCN Guidelines for Pancreatic Adenocarcinoma https://beta.finance.yahoo.com/news/merrimack-​announces-inclusion-onivyde-irinotecan-...

Analysen

  
Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Aktie & Unternehmen

  
Branche Pharmazeutik
Herkunft USA
Website www.merrimack.com
Aktienanzahl 13,3 Mio. (Stand: 11.09.17)
Marktkap. 124,7 Mio. $

Dividenden & Splits

  
06.09.17 Reverse Split 10:1
30.05.17 Dividende   10,00 EUR

Ähnliche Aktien

  
Name
last
change_rel
 
Achieve Life Science 3,40 € +18,47%
Editas Medicine 33,86 € -0,67%
KalVista Pharmaceuticals 7,20 € -4,51%
Biopharmx 0,195 € -12,16%
Catabasis Pharmaceuticals 0,725 € -4,10%